Biogen (NASDAQ:BIIB – Get Rating) and Revolution Medicines (NASDAQ:RVMD – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Profitability This table compares Biogen and Revolution Medicines’ net margins, return […]
Matthew Scalo: Okay. Good afternoon, and welcome to the Myriad Genetics First Quarter 2023 Earnings Call. During the call, we will review the financial results we released today.
On DNA Day, Canada should be inspired by the lifesaving discoveries of its researchers. However, lack of funding threatens Canadian researchers’ ability to meet the challenges of the future.